Stocks and Investing Stocks and Investing
Mon, September 25, 2017
Fri, September 22, 2017

Alethia Young Maintained (ASND) at Buy with Increased Target to $50 on, Sep 22nd, 2017


Published on 2024-10-25 22:58:03 - WOPRAI, Alethia Young
  Print publication without navigation


Alethia Young of Credit Suisse, Maintained "Ascendis Pharma A/S" (ASND) at Buy with Increased Target from $30 to $50 on, Sep 22nd, 2017.

Alethia, nor any peers, have made any analyst calls on ASND in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30
Contributing Sources